Anthony S. Marucci is CEO & President at Celldex Therapeutics, Inc. (CLDX). They have made 7 open-market trades across 1 company since 2009, most recently 2024-11-11.
CIK 0001429933
6 open-market purchases totalling $580K since 2009, against 1 sale. Across 6 scored buys the stock is up 21.3% at ninety days, and 19.7 points ahead of the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| CLDX | 40,284 | $1.1M |
Shares reported on the most recent Form 4, priced at the 2024-11-12 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 17% | 17% | 17% |
| Avg Move | +11.4% | +25.4% | +21.3% |
| Alpha | +15.4% | +24.7% | +19.7% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CLDX | BUY | 2024-11-11 | 2024-11-12 | $26.82 | $308K | -0.5% | -2.6% | -20.7% |
| CLDX | SELL | 2022-08-15 | 2022-08-17 | $37.66 | $4.5M | -12.7% | -20.2% | +0.1% |
| CLDX | BUY | 2020-06-09 | 2020-06-10 | $3.06 | $46K | +188.9% | +161.3% | +154.8% |
| CLDX | BUY | 2015-08-13 | 2015-08-14 | $16.81 | $97K | -29.9% | -1.6% | -1.6% |
| CLDX | BUY | 2011-08-09 | 2011-08-10 | $2.41 | $36K | -29.9% | -1.6% | -1.6% |
| CLDX | BUY | 2010-09-10 | 2010-09-13 | $3.45 | $41K | -29.9% | -1.6% | -1.6% |
| CLDX | BUY | 2009-11-09 | 2009-11-09 | $5.10 | $51K | -29.9% | -1.6% | -1.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.